Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 135Lymphoid 82Myeloid 33Plasma cell 18Classical hematology 17Sarcoma 15Dermatologic 6Other neoplasm 3Other 1Genitourinary 1CNS 1Breast 1

Conditions

Neuroblastoma 60Central Nervous System Neoplasms 39Brain Neoplasms 34Medulloblastoma 26Astrocytoma 15Rhabdoid Tumor 12Glioblastoma 12Ependymoma 12Sarcoma 10Glioma 9Testicular Neoplasms 8Oligodendroglioma 7Choroid Plexus Neoplasms 7Teratoma 6Optic Nerve Glioma 6Neuroectodermal Tumors, Primitive, Peripheral 6Gliosarcoma 6Testicular Germ Cell Tumor 5Retinoblastoma 5Neuroectodermal Tumors, Primitive 5Neoplasms 5Lymphoma 5Recurrence 4Ovarian Neoplasms 4Ganglioneuroblastoma 4Familial ependymoma 4Carcinoma, Renal Cell 4Spinal Cord Neoplasms 3Rhabdomyosarcoma 3Osteosarcoma 3

Interventions

Psychiatric Rehabilitation 5Melphalan 5Cyclophosphamide 5Methylprednisolone 4Flow Cytometry 4Busulfan 4Early Intervention, Educational 3Antilymphocyte Serum 3Alemtuzumab 3fludarabine phosphate 2Radiotherapy 2Immunologic Techniques 2Filgrastim 2Azacitidine 2thymoglobulin 1tanespimycin 1sargramostim 1ruxolitinib 1rucaparib 1pembrolizumab 1neratinib 1ixabepilone 1fosphenytoin 1fludarabine 1dexamethasone acetate 1dexamethasone 21-phosphate 1cc-486 1bempegaldesleukin 1aldesleukin 1abiraterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Etoposide × CNS × Clear all
NCT00357500 2014-10-01

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
101 enrolled 10 charts
CNSLymphoidOther hematologic neoplasmSarcoma

Leukemia, Lymphoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡